Suppr超能文献

苦参碱诱导全反式维甲酸耐药性急性早幼粒细胞白血病(NB4-LR1)细胞分化敏感性恢复过程中PML/Rarα融合蛋白的自噬及泛素介导的蛋白水解降解:体内外研究

Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/Rarα Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: in Vitro and in Vivo Studies.

作者信息

Wu Dijiong, Shao Keding, Zhou Qihao, Sun Jie, Wang Ziqi, Yan Fei, Liu Tingting, Wu Xiangping, Ye Baodong, Huang He, Zhou Yuhong

机构信息

Department of Hematology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.

First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.

出版信息

Cell Physiol Biochem. 2018;48(6):2286-2301. doi: 10.1159/000492646. Epub 2018 Aug 16.

Abstract

BACKGROUND/AIMS: Although the cure rate of acute promyelocytic leukemia (APL) has exceeded 90%, the relapse/refractory APL that resistant to all-trans retinoic acid (ATRA) or ATO was still serious concern. Matrine (MAT) could improve the differentiation ability of ATRA-resistant APL cells. This study aimed to explore how the APL-specific fusion protein was degraded in ATRA-resistant APL with the application of MAT and ATRA.

METHODS

ATRA-sensitive (NB4) and ATRA-resistant (NB4-LR1) cell lines were used. Nitroblue tetrazolium reduction assay and flow cytometry were used to detect the differentiation ability. The activity of ubiquitin-proteasome and autophagy-mediated pathways in both cells treated with ATRA with or without MAT were compared in protein and mRNA level (Western blot analysis, qRT-PCR), the Fluorescent substrate Suc-LLVY-AMC detection was used to detect the activity of proteasome, and electron microscope for observing autophagosome. MG 132(proteasome inhibitor), rapamycin (autophagy activator), hydroxychloroquine (lysosomal inhibitor) and STI571 [retinoic acid receptor alpha (RARα) ubiquitin stabilizer] were used as positive controls. The effect of MAT was observed in vivo using xenografts.

RESULTS

MAT improved the sensitivity of NB4-LR1cells to ATRA treatment, which was consistent with the expression of PML-RARα fusion protein. MAT promoted the ubiquitylation level in NB4-LR1. MG 132 induced the decrease in RARα in both cell lines, and hampered the differentiation of NB4 cells. MAT also promoted the autophagy in NB4-LR1 cells, with an increase in microtubule-associated protein 1 light chain3 (LC3)-II and LC3-II/LC3-I ratio and exhaustion of P62. The expression of LC3II increased significantly in the MAT and ATRA + MAT groups in combination with lysosomal inhibitors. A similar phenomenon was observed in mouse xenografts. MAT induced apoptosis and differentiation.

CONCLUSIONS

Autophagy and ubiquitin-mediated proteolytic degradation of PML/RARα fusion protein are crucial in MAT-induced differentiation sensitivity recovery of NB4-LR1 cells.

摘要

背景/目的:尽管急性早幼粒细胞白血病(APL)的治愈率已超过90%,但对全反式维甲酸(ATRA)或三氧化二砷(ATO)耐药的复发/难治性APL仍然是一个严重问题。苦参碱(MAT)可提高对ATRA耐药的APL细胞的分化能力。本研究旨在探讨在MAT和ATRA应用下,APL特异性融合蛋白在对ATRA耐药的APL中是如何降解的。

方法

使用对ATRA敏感的(NB4)和对ATRA耐药的(NB4-LR1)细胞系。采用硝基蓝四氮唑还原试验和流式细胞术检测分化能力。在蛋白质和mRNA水平(蛋白质免疫印迹分析、qRT-PCR)上比较用或不用MAT处理的两种细胞中泛素-蛋白酶体和自噬介导途径的活性,用荧光底物Suc-LLVY-AMC检测法检测蛋白酶体活性,用电子显微镜观察自噬体。MG 132(蛋白酶体抑制剂)、雷帕霉素(自噬激活剂)、羟氯喹(溶酶体抑制剂)和STI571 [维甲酸受体α(RARα)泛素稳定剂]用作阳性对照。使用异种移植在体内观察MAT的作用。

结果

MAT提高了NB4-LR1细胞对ATRA治疗的敏感性,这与PML-RARα融合蛋白表达一致。MAT促进了NB4-LR1中的泛素化水平。MG 132诱导两种细胞系中RARα减少,并阻碍NB4细胞的分化。MAT还促进了NB4-LR1细胞中的自噬,微管相关蛋白1轻链3(LC3)-II和LC3-II/LC3-I比值增加,P62耗竭。在MAT组以及与溶酶体抑制剂联合的ATRA + MAT组中,LC3II的表达显著增加。在小鼠异种移植中观察到类似现象。MAT诱导凋亡和分化。

结论

自噬和泛素介导的PML/RARα融合蛋白的蛋白水解降解在MAT诱导的NB4-LR1细胞分化敏感性恢复中起关键作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验